Voloridge Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-69,712
| Closed | -$28.1M | – | 1382 |
|
|
2024
Q4 | $28.1M | Sell |
69,712
-67,376
| -49% | -$27.1M | 0.1% | 265 |
|
|
2024
Q3 | $63.8M | Buy |
137,088
+87,312
| +175% | +$40.6M | 0.23% | 110 |
|
|
2024
Q2 | $23.3M | Sell |
49,776
-51,401
| -51% | -$24.1M | 0.09% | 315 |
|
|
2024
Q1 | $42.3M | Buy |
101,177
+19,827
| +24% | +$8.29M | 0.15% | 191 |
|
|
2023
Q4 | $33.1M | Buy |
81,350
+48,597
| +148% | +$19.8M | 0.13% | 205 |
|
|
2023
Q3 | $11.4M | Buy |
32,753
+18,753
| +134% | +$6.52M | 0.06% | 428 |
|
|
2023
Q2 | $4.93M | Buy |
+14,000
| New | +$4.93M | 0.02% | 677 |
|
|
2023
Q1 | – | Sell |
-60,891
| Closed | -$17.6M | – | 1637 |
|
|
2022
Q4 | $17.6M | Buy |
+60,891
| New | +$17.6M | 0.1% | 292 |
|
|
2022
Q3 | – | Sell |
-21,735
| Closed | -$6.13M | – | 1634 |
|
|
2022
Q2 | $6.13M | Buy |
+21,735
| New | +$6.13M | 0.03% | 603 |
|
|
2022
Q1 | – | Sell |
-139,353
| Closed | -$30.6M | – | 1730 |
|
|
2021
Q4 | $30.6M | Sell |
139,353
-397,543
| -74% | -$87.3M | 0.17% | 156 |
|
|
2021
Q3 | $97.4M | Buy |
536,896
+284,222
| +112% | +$51.6M | 0.63% | 11 |
|
|
2021
Q2 | $50.9M | Buy |
252,674
+43,799
| +21% | +$8.83M | 0.35% | 40 |
|
|
2021
Q1 | $44.9M | Sell |
208,875
-51,910
| -20% | -$11.2M | 0.33% | 61 |
|
|
2020
Q4 | $61.6M | Buy |
260,785
+195,175
| +297% | +$46.1M | 0.52% | 31 |
|
|
2020
Q3 | $17.9M | Buy |
+65,610
| New | +$17.9M | 0.15% | 168 |
|
|
2020
Q1 | – | Sell |
-97,763
| Closed | -$21.4M | – | 1430 |
|
|
2019
Q4 | $21.4M | Buy |
+97,763
| New | +$21.4M | 0.42% | 39 |
|
|
2018
Q1 | – | Sell |
-287,899
| Closed | -$43.1M | – | 671 |
|
|
2017
Q4 | $43.1M | Sell |
287,899
-4,858
| -2% | -$728K | 0.94% | 17 |
|
|
2017
Q3 | $44.5M | Buy |
+292,757
| New | +$44.5M | 0.99% | 19 |
|
|
2016
Q2 | – | Sell |
-79,032
| Closed | -$6.28M | – | 409 |
|
|
2016
Q1 | $6.28M | Buy |
+79,032
| New | +$6.28M | 0.15% | 131 |
|